☆ 4.7 Editorial Material

Anti-tumour necrosis factor α therapy in patients with rheumatoid arthritis results in a significant and long-lasting decrease of concomitant glucocorticoid treatment

ANNALS OF THE RHEUMATIC DISEASES (2009)

期刊

ANNALS OF THE RHEUMATIC DISEASES

卷 68, 期 12, 页码 1934-1936

出版社

B M J PUBLISHING GROUP

DOI: 10.1136/ard.2009.111807

关键词

-

类别

Rheumatology

向作者/读者索取更多资源

Protocol

Reagent

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Rheumatology

Tumour necrosis factor inhibitor use during pregnancy is associated with increased birth weight of rheumatoid arthritis patients' offspring

Hieronymus T. W. Smeele, Esther Roder, Annemarie G. M. G. J. Mulders, Eric A. P. Steegers, Radboud J. E. M. Dolhain

Summary: This study is the first to show that the use of TNFi during pregnancy is associated with increased birth weight in offspring of women with well-controlled RA. Further research is needed to explore the underlying mechanism of TNF inhibition on birth weight and its long-term consequences for the offspring.

ANNALS OF THE RHEUMATIC DISEASES (2022)

添加到收藏夹

Article Pharmacology & Pharmacy

Salvianolate Ameliorates Osteopenia and Improves Bone Quality in Prednisone-Treated Rheumatoid Arthritis Rats by Regulating RANKL/RANK/OPG Signaling

Xiang Gao, Qingyun Wu, Xinle Zhang, Jia Tian, Dahong Liang, Yalin Min, Jiaqi Lu, Xuemei Zhang, Liao Cui, Bilian Xu, Yanzhi Liu

Summary: This study investigated the potential of salvianolate treatment in ameliorating osteopenia in prednisone-treated RA rats. The results showed that Salvianolate significantly improved bone density and bone quality.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Immunology

Antcin K Inhibits TNF-α, IL-1β and IL-8 Expression in Synovial Fibroblasts and Ameliorates Cartilage Degradation: Implications for the Treatment of Rheumatoid Arthritis

David Achudhan, Shan-Chi Liu, Yen-You Lin, Chien-Chung Huang, Chun-Hao Tsai, Chih-Yuan Ko, I-Ping Chiang, Yueh-Hsiung Kuo, Chih-Hsin Tang

Summary: The study demonstrates that Antcin K, a compound isolated from Antrodia cinnamomea, shows anti-inflammatory effects by inhibiting proinflammatory cytokine production in human rheumatoid synovial fibroblasts. This indicates the potential of Antcin K in treating rheumatoid arthritis by reducing inflammation.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Rheumatology

Effect of tapered versus stable treatment with tumour necrosis factor inhibitors on disease flares in patients with rheumatoid arthritis in remission: a randomised, open label, non-inferiority trial

Siri Lillegraven, Nina Paulshus Sundlisaeter, Anna-Birgitte Aga, Joseph Sexton, Inge Christoffer Olsen, Ase Stavland Lexberg, Tor Magne Madland, Hallvard Fremstad, Christian A. Hoili, Gunnstein Bakland, Cristina Spada, Hilde Haukeland, Inger Myrnes Hansen, Ellen Moholt, Till Uhlig, Daniel H. Solomon, Desiree Van der Heijde, Tore K. Kvien, Espen A. Haavardsholm

Summary: This study aimed to assess the effect of tapering tumor necrosis factor inhibitor (TNFi) to withdrawal compared with stable treatment on the risk of disease activity flares in patients with rheumatoid arthritis (RA) in remission for more than 1 year. The results showed that in the tapering TNFi group, 63% experienced a flare during 12 months, compared to 5% in the stable TNFi group. Therefore, tapering TNFi to discontinuation is not non-inferior to continued stable treatment.

ANNALS OF THE RHEUMATIC DISEASES (2023)

添加到收藏夹

Article Rheumatology

Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial

Andra-Rodica Balanescu, Gustavo Citera, Virginia Pascual-Ramos, Deepak L. Bhatt, Carol A. Connell, David Gold, All-Shine Chen, Gosford Sawyerr, Andrea B. Shapiro, Janet E. Pope, Hendrik Schulze-Koops

Summary: This study aimed to characterize infections in patients with rheumatoid arthritis (RA) receiving different treatment regimens. The results showed that tofacitinib had a higher risk of infections compared to tumor necrosis factor inhibitors (TNFi). These findings may provide insights for future treatment decisions.

ANNALS OF THE RHEUMATIC DISEASES (2022)

添加到收藏夹

Article Immunology

Effects of RETN polymorphisms on treatment response in rheumatoid arthritis patients receiving TNF-α inhibitors and utilization of machine-learning algorithms

Woorim Kim, Soo Jin Oh, Nga Thi Trinh, Jin Yeon Gil, In Ah Choi, Ji Hyoun Kim, Joo Hee Kim, Ju-Yang Jung, Jinhyun Kim, Hyoun-Ah Kim, Kyung Eun Lee

Summary: This study aimed to investigate the effects of genetic polymorphisms in RETN on the remission of RA patients receiving TNF-alpha inhibitors, and use machine learning algorithms to predict remission. The results showed that the most significant features associated with the efficacy of TNF-alpha inhibitors included sex, age, hypertension, sulfasalazine, and several genetic polymorphisms. The elastic net algorithm was found to be the best method for predicting remission in RA patients treated with TNF-alpha inhibitors.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

添加到收藏夹

Article Rheumatology

Exposure to specific tumour necrosis factor inhibitors and risk of demyelinating and inflammatory neuropathy in cohorts of patients with inflammatory arthritis: a collaborative observational study across five Nordic rheumatology registers

Benedicte Delcoigne, Tine Iskov Kopp, Elizabeth Arkema, Karin Hellgren, Sella Aarrestad Provan, Heikki Relas, Kalle Aaltonen, Nina Trokovic, Bjorn Gudbjornsson, Gerdur Grondal, Eirik Klami Kristianslund, Jesper Lindhardsen, Lene Dreyer, Johan Askling

Summary: This study compared the incidences of neuroinflammatory events in patients with rheumatoid arthritis (RA) or spondyloarthritis (SpA) starting a tumor necrosis factor inhibitor (TNFi). The results showed that the choice of specific TNFi did not seem to play an important role in the risk of neuroinflammatory events.

RMD OPEN (2023)

添加到收藏夹

Article Rheumatology

Obesity potentially protects against systemic bone loss in patients with rheumatoid arthritis treated with tumour necrosis factor inhibitors

S. Y. Lee, K-H Jung, S-G Park, S-R Kwon, W. Park, M. J. Lim

Summary: The study found that one year of TNF inhibitor treatment did not stop systemic bone loss in rheumatoid arthritis patients, but obesity may have protective effects against bone loss.

CLINICAL AND EXPERIMENTAL RHEUMATOLOGY (2021)

添加到收藏夹

Article Rheumatology

Differing time-orders of inflammation decrease between ACPA subsets in RA patients suggest differences in underlying inflammatory pathways

Xanthe M. E. Matthijssen, Ellis Niemantsverdriet, Saskia Le Cessie, Annette H. M. Van der Helm-van Mil

Summary: This study found that the decrease of inflammatory features usually occurs simultaneously in patients with RA and undifferentiated arthritis, including in ACPA subgroups, but synovitis decrease typically precedes tenosynovitis decrease. Additionally, in ACPA-positive patients, synovitis decrease occurs before osteitis decrease.

RHEUMATOLOGY (2021)

添加到收藏夹

Article Pharmacology & Pharmacy

Identification of Tumor Necrosis Factor-Alpha (TNF-α) Inhibitor in Rheumatoid Arthritis Using Network Pharmacology and Molecular Docking

Liang Liang Bai, Hao Chen, Peng Zhou, Jun Yu

Summary: This study investigated the molecular mechanisms of white peony in treating immune inflammatory diseases of rheumatoid arthritis and TNF-alpha inhibitors by utilizing network pharmacology and molecular docking. The results identified potential therapeutic targets for RA from the active ingredients of white peony and highlighted the immune-inflammatory signaling pathways involved in the treatment of RA. Molecular docking analysis suggested that mairin was the most suitable natural TNFis from white peony.

FRONTIERS IN PHARMACOLOGY (2021)

添加到收藏夹

Article Rheumatology

Trajectory clusters of radiographic progression in patients with rheumatoid arthritis: associations with clinical variables

Alexander Platzer, Farideh Alasti, Josef S. Smolen, Daniel Aletaha, Helga Radner, Stephan Blueml

Summary: This study identified four distinct clusters of radiographic progression over a 2-year period in patients with rheumatoid arthritis (RA), including stable, relentless progression, improvement, and both ways, confirming the robustness of the clusters using different clustering methods. Regression models found disease duration, baseline C-reactive protein (CRP) and SHS, and treatment status as predictors for cluster assignment.

ANNALS OF THE RHEUMATIC DISEASES (2022)

添加到收藏夹

Editorial Material Ophthalmology

Ocular toxoplasmosis following anti-tumour necrosis factor-α therapy combined with oral methotrexate therapy: A case report and review of literature

Gazal Patnaik, Richa Pyare, V. V. Kaushik, Parthopratim Dutta Majumder

Summary: This case highlights the importance of early recognition and management of opportunistic infections in patients receiving biological therapy.

EUROPEAN JOURNAL OF OPHTHALMOLOGY (2023)

添加到收藏夹

Article Cell & Tissue Engineering

Potency of Bone Marrow-Derived Mesenchymal Stem Cells and Indomethacin in Complete Freund's Adjuvant-Induced Arthritic Rats: Roles of TNF-α, IL-10, iNOS, MMP-9, and TGF-β1

Eman A. Ahmed, Osama M. Ahmed, Hanaa I. Fahim, Tarek M. Ali, Basem H. Elesawy, Mohamed B. Ashour

Summary: The study aimed to compare the effects of BM-MSCs and IMC alone or in combination on arthritic rats. The combined treatment showed the most potent effect in reducing symptoms of rheumatoid arthritis in rats.

STEM CELLS INTERNATIONAL (2021)

添加到收藏夹

Article Plant Sciences

Bromelain Extract Exerts Antiarthritic Effects via Chondroprotection and the Suppression of TNF-α-Induced NF-κB and MAPK Signaling

Peraphan Pothacharoen, Rujirek Chaiwongsa, Theerawut Chanmee, Orapin Insuan, Thanchanok Wongwichai, Phornpimon Janchai, Pilanee Vaithanomsat

Summary: Bromelain, a protease mixture found in pineapple, has beneficial biological properties and exhibits anti-arthritic activities. It protects cartilage from degradation and decreases the expression of inflammatory cytokines in synovial fibroblasts by suppressing NF-kappa B and MAPK signaling pathways.

PLANTS-BASEL (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics

Dan-in Jang, A-Hyeon Lee, Hye-Yoon Shin, Hyo-Ryeong Song, Jong-Hwi Park, Tae-Bong Kang, Sang-Ryong Lee, Seung-Hoon Yang

Summary: TNF-α was originally identified as a factor causing tumor necrosis but has also been recognized as a pathological component of autoimmune diseases. Its signaling pathways play important roles in cellular responses, and inappropriate activation can lead to chronic inflammation and autoimmune diseases. TNF-α inhibitors have been developed as effective therapeutic tools for various autoimmune diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

添加到收藏夹

Article Rheumatology

Development of prediction models to select older RA patients with comorbidities for treatment with chronic low-dose glucocorticoids

Linda Hartman, Jose A. P. da Silva, Frank Buttgereit, Maurizio Cutolo, Daniela Opris-Belinski, Zoltan Szekanecz, Pavol Masaryk, Marieke J. H. Voshaar, Martijn W. Heymans, Willem F. Lems, Desiree M. F. M. van der Heijde, Maarten Boers

Summary: This study aims to develop prediction models for individual harm and benefit outcomes in elderly RA patients treated with low-dose glucocorticoid therapy. The results suggest that baseline factors have limited predictive value in determining the chance of benefit or harm.

RHEUMATOLOGY (2023)

添加到收藏夹

Article Rheumatology

Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region

Alain Lescoat, Doerte Huscher, Nils Schoof, Paolo Airo, Jeska De Vries-Bouwstra, Gabriela Riemekasten, Eric Hachulla, Andrea Doria, Edoardo Rosato, Nicolas Hunzelmann, Carlomaurizio Montecucco, Armando Gabrielli, Anna-Maria Hoffmann-Vold, Oliver Distler, Jennifer Ben Shimol, Maurizio Cutolo, Yannick Allanore

Summary: The prevalence and characteristics of SSc-associated interstitial lung disease (SSc-ILD) vary between geographical regions. This study aimed to explore the differences in prevalence, phenotype, treatment, and prognosis in patients with SSc-ILD from different regions in the EUSTAR database. The results showed significant variations in clinical characteristics, survival rates, and treatment approaches among different regions.

RHEUMATOLOGY (2023)

添加到收藏夹

Letter Rheumatology

Optimizing the reporting and conduct of systematic literature reviews and meta-analyses

Zhivana Boyadzhieva, Sabrina Mai Nielsen, Frank Buttgereit, Robin Christensen, Andriko Palmowski

ZEITSCHRIFT FUR RHEUMATOLOGIE (2023)

添加到收藏夹

Article Rheumatology

Efficacy and Safety of ABBV-3373, a Novel Anti-Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody-Drug Conjugate, in Adults with Moderate-to-Severe Rheumatoid Arthritis Despite Methotrexate Therapy: A Randomized, Double-Blind, Active-Controlled Proof-of-Concept Phase IIa Trial

Frank Buttgereit, Jacob Aelion, Bernadette Rojkovich, Anna Zubrzycka-Sienkiewicz, Su Chen, Yang Yang, Dilek Arikan, Ronilda D'Cunha, Yinuo Pang, Hartmut Kupper, Timothy Radstake, Howard Amital

Summary: This study aimed to assess the efficacy and safety of ABBV-3373, a novel antibody-drug conjugate (ADC), compared to adalimumab in patients with rheumatoid arthritis (RA). The results showed that ABBV-3373 had superior efficacy and safety compared to historical adalimumab, supporting its continued development for RA treatment.

ARTHRITIS & RHEUMATOLOGY (2023)

添加到收藏夹

Editorial Material Rheumatology

Tocilizumab in Giant Cell Arteritis: Better Understanding the Benefits

Frank Buttgereit, Andriko Palmowski, Idil Esen, Elisabeth Brouwer

ARTHRITIS & RHEUMATOLOGY (2023)

添加到收藏夹

Article Immunology

Comprehensive autoantibody profiles in systemic sclerosis: Clinical cluster analysis

Jakob Hoeppner, Christoph Tabeling, Vincent Casteleyn, Claudia Kedor, Wolfram Windisch, Gerd Ruediger Burmester, Doerte Huscher, Elise Siegert

Summary: The aim of this study was to comprehensively analyze the serum autoantibody status in patients with systemic sclerosis (SSc) and correlate it with the clinical course of the disease. The study found that specific autoantibodies are associated with specific clinical manifestations, while the association of some rare antibodies is not fully clarified. The results of this study reveal important associations between the serologic status of SSc patients and disease manifestation, comorbidities, and complications.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Article Geriatrics & Gerontology

Association of kidney function and albuminuria with frailty worsening and death in very old adults

Nina Mielke, Alice Schneider, Muhammad Helmi Barghouth, Natalie Ebert, Markus van der Giet, Doerte Huscher, Martin K. Kuhlmann, Elke Schaeffner

Summary: This study investigates the association between kidney function decline and albuminuria with frailty worsening or death in very old adults. The findings suggest that both advanced stages of CKD and albuminuria are independently associated with an increased risk of frailty worsening and death in older adults.

AGE AND AGEING (2023)

添加到收藏夹

Letter Respiratory System

Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis

Kai-Helge Schmidt, Katrin Milger, Christine Pausch, Doerte Huscher, David Pittrow, Ekkehard Gruenig, Gerd Staehler, Henning Gall, Oliver Distler, Dirk Skowasch, Michael Halank, Heinrike Wilkens, Matthias Held, Hans Klose, Marius M. Hoeper

EUROPEAN RESPIRATORY JOURNAL (2023)

添加到收藏夹

Article Immunology

Facilitated Subcutaneous Immunoglobulin Treatment in Patients with Immunodeficiencies: the FIGARO Study

Michael Borte, Leif G. G. Hanitsch, Nizar Mahlaoui, Maria Fasshauer, Dorte Huscher, Matthaios Speletas, Maria Dimou, Marta Kamieniak, Corinna Hermann, David Pittrow, Cinzia Milito

Summary: The FIGARO study aims to provide insights on the real-world utilization and tolerability of fSCIG for PID and SID patients. This prospective, multicenter study analyzed medical records, charts, and diaries of patients receiving fSCIG treatment for at least 1 year. The results showed that fSCIG is a feasible, well-tolerated treatment option with good infection control for both PID and SID patients.

JOURNAL OF CLINICAL IMMUNOLOGY (2023)

添加到收藏夹

Article Immunology

Serum proteomics in giant cell arteritis in response to a three-day pulse of glucocorticoid followed by tocilizumab monotherapy (the GUSTO trial)

Lisa Christ, Andrea D. Gloor, Florian Kollert, Timo Gaber, Frank Buttgereit, Stephan Reichenbach, Peter M. Villiger

Summary: This study reported proteome analyses in patients with newly diagnosed, untreated giant cell arteritis (GCA), as well as the changes of protein expression upon treatment with glucocorticoids (GC) and/or tocilizumab (TCZ). The majority of protein changes occurred within 10 days of treatment initiation. GC and TCZ had differential effects on protein regulation. CCL7, CXCL9, and MMP12 are biomarkers reflecting disease activity.

FRONTIERS IN IMMUNOLOGY (2023)

添加到收藏夹

Letter Cardiac & Cardiovascular Systems

Kidney Measures and Risk of Incident Heart Failure Among Older Adults

Antonios Douros, Alice Schneider, Natalie Ebert, Anne-Katrin Fietz, Dorte Huscher, Martin K. Kuhlmann, Peter Martus, Nina Mielke, Markus van der Giet, Volker Wenning, Elke Schaeffner

JACC-HEART FAILURE (2023)

添加到收藏夹

Article Medicine, General & Internal

Characterizing Sjogren-Associated Fatigue: A Distinct Phenotype from ME/CFS

Laura Kim, Claudia Kedor, Frank Buttgereit, Harald Heidecke, Desiree Schaumburg, Carmen Scheibenbogen

Summary: Fatigue is a common and debilitating symptom in primary Sjogren's syndrome (pSS) patients. This study aimed to evaluate fatigue and other symptoms in pSS patients and investigate if there is symptom overlap with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). The severity of pSS symptoms and disease activity were assessed, and hand grip strength (HGS) and autoantibody levels were measured. Some pSS patients experienced severe fatigue and exhibited higher levels of pain, depression, and sleep disturbances. Four out of eighteen pSS patients met the criteria for ME/CFS. HGS parameters correlated strongly with fatigue severity but fully recovered after exertion, unlike ME/CFS. Elevated levels of certain autoantibodies were associated with disease activity but not fatigue severity. Only a small subgroup of pSS patients fulfilled the criteria for ME/CFS, and post-exertional malaise was primarily triggered by mental/emotional exertion rather than physical exertion. HGS assessment is an objective measure for overall fatigue severity.

JOURNAL OF CLINICAL MEDICINE (2023)

添加到收藏夹

Article Oncology

Insights into Facilitated Subcutaneous Immunoglobulin Use in Patients with Secondary Immunodeficiency Diseases: A FIGARO Subgroup Analysis

Maria Dimou, Matthaios Speletas, Cinzia Milito, Aleksandra Pyzik, Doerte Huscher, Marta Kamieniak, David Pittrow, Michael Borte

Summary: The study aimed to evaluate the clinical use and tolerability of facilitated subcutaneous immunoglobulin (fSCIG) in patients with secondary immunodeficiency (SID). The results demonstrated that fSCIG had a positive impact on the treatment experience of SID patients, with good efficacy and tolerability.

CANCERS (2023)

添加到收藏夹

Article Rheumatology

Sex and age do not modify the association between glucocorticoids and bone mineral density in patients with rheumatoid arthritis: a cross-sectional study

Andriko Palmowski, Zhivana Boyadzhieva, Sabrina M. Nielsen, Burkhard Muche, Sandra Hermann, Maarten Boers, Henning Bliddal, Robin Christensen, Edgar Wiebe, Frank Buttgereit

Summary: This study investigated whether the association between glucocorticoid (GC) use and reduced bone mineral density (BMD) in rheumatoid arthritis (RA) patients is modified by sex or age. The results showed no significant differences in the association between GC use and BMD reduction, regardless of sex or age.

ARTHRITIS RESEARCH & THERAPY (2023)

添加到收藏夹

Article Rheumatology

No association between methotrexate and impaired bone mineral density in a cohort of patients with polymyalgia rheumatica, giant cell arteritis, granulomatosis with polyangiitis and other vasculitides-a cross-sectional analysis with dose-response analyses

Andriko Palmowski, Mitsuteru Akahoshi, Burkhard Muche, Zhivana Boyadzhieva, Sandra Hermann, Chikashi Terao, Edgar Wiebe, Frank Buttgereit

Summary: This study aimed to investigate the association between methotrexate (MTX) use and bone mineral density (BMD) in patients with polymyalgia rheumatica (PMR) and various forms of vasculitis. The results showed that there was no association between MTX use and BMD levels. This study is important for evaluating the use of MTX and its impact on BMD in patients with PMR and vasculitis.

RHEUMATOLOGY INTERNATIONAL (2023)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.